PDCD1 and type 1 diabetes mellitus: A recent cohort study also showed that higher levels of circulating immune checkpoint molecules, especially CD137/4-1BB and PD-1, may serve as prognostic biomarkers for new-onsets T1D and risk factors for the growth of an additional autoimmune disease (102).